Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration

Abstract

The wide range of nephrotoxicity after systemic bevacizumab has been well documented. Our case describes a self-limited biopsy-proven membranous nephropathy after intravitreal bevacizumab injections.